Safety profile and side effects of infliximab and adalimumab in inflammatory bowel disease at a referral center in northeastern Brazil

Safety profile and side effects of infliximab and adalimumab in inflammatory bowel disease at a referral center in northeastern Brazil

Introduction: Anti-tumor necrosis factor-alpha agents (Anti-TNF-alpha) are an effective treatment option in patients with moderate and severe inflammatory bowel disease (IBD). Objectives: To evaluate safety profile of infliximab (IFX) and adalilumab (ADA) in IBD patients over a 10-year period at a r...

Full description

Bibliographic Details
Main Authors: Joelma Aurélio de Sousa Santos, Christopher Falcão Correia, Francisca Antônia do Vale Gomes, Isabele de Sá Silveira Melo, José Armando Pessoa Neto, Loraine Maria Silva Andrade, Ranna Caroline Bezerra Siebra, Marcellus Henrique Loiola Ponte de Souza, Lúcia Libanez Bessa Campelo Braga Braga
Format: Article
Language:English
Published: Universidade Federal do Ceará 2024-02-01
Series:Revista de Medicina da UFC
Subjects:
inflammatory bowel diseases
infliximab
adalimumab
safety
Online Access:http://periodicos.ufc.br/revistademedicinadaufc/article/view/77941

Internet

http://periodicos.ufc.br/revistademedicinadaufc/article/view/77941

Similar Items